Rockwell Medical, Inc.
RMTI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001041024
No open-market purchases or sales by Rockwell Medical, Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Rockwell Medical, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Rockwell Medical, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Dawson Joseph H | Director | 12,133 | Jul 6, 2026 | 2 |
| Nissenson Allen | Director | 23,892 | Jul 6, 2026 | 1 |
| Lau Joan | Director | 20,944 | Jul 6, 2026 | 1 |
| Radie Robert S | Director | 23,985 | Jul 6, 2026 | 1 |
| Cooper John G | Director | 23,670 | Jul 6, 2026 | 2 |
| Chole Timothy | SVP and CCO | 27,285 | Jul 6, 2026 | 4 |
| Hunter Heather | Chief Operating Officer | 28,007 | Jul 6, 2026 | 4 |
| Timmins Megan C. | EVP, CLO & Secretary | 31,240 | Jul 6, 2026 | 3 |
| Neri Jesse | SVP and CFO | 27,239 | Jul 6, 2026 | 5 |
| Strobeck Mark | President and CEO | 62,349 | Jul 6, 2026 | 4 |
| Ravich Mark H | Director | 148,831 | May 21, 2025 | 0 |
| Smiley Andrea Heslin | Director | 142,062 | May 21, 2025 | 0 |
| Irrevocable Larson Family Investment Trust | 10% Owner | 3,557,500 | Apr 15, 2025 | 0 |
| McGarry Paul E | SVP, Finance and CAO | 28,515 | Mar 21, 2023 | 0 |
| Hoffman Marc L | Chief Medical Officer | 25,665 | Mar 21, 2023 | 0 |
| Skibsted Russell | See Remarks | – | Sep 13, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 (view filing) | Jan 2 | 3 days | Hunter HeatherChief Operating Officer | SSale | −2.87K | $0.84 | −$2.41K | −2.1%132.5K after | 10b5-1 |
| Jan 5, 2026 (view filing) | Jan 2 | 3 days | Neri JesseSVP and CFO | SSale | −886 | $0.84 | −$744.24 | −0.7%124.8K after | 10b5-1 |
| Nov 18, 2025 (view filing) | Nov 18 | Same day | Cooper John GDirector | SSale | −5.08K | $0.87 | −$4.42K | −3.5%140.4K after | |
| Oct 8, 2025 (view filing) | Oct 1 | 7 daysLate | Hunter HeatherSVP, Chief Operating Officer | SSale | −2.87K | $1.19 | −$3.41K | −2.1%135.4K after | 10b5-1 |
| Oct 1, 2025 (view filing) | Oct 1 | Same day | Chole TimothySVP and CCO | SSale | −2.87K | $1.19 | −$3.41K | −2.2%125.3K after | 10b5-1 |
| Oct 1, 2025 (view filing) | Oct 1 | Same day | Neri JesseSVP and CFO | SSale | −886 | $1.19 | −$1.05K | −0.7%125.7K after | 10b5-1 |
| Oct 1, 2025 (view filing) | Oct 1 | Same day | Strobeck MarkPresident and CEO | SSale | −6.93K | $1.19 | −$8.24K | −2.1%330.8K after | 10b5-1 |
| Jul 3, 2025 (view filing) | Jul 1 | 2 days | Chole TimothySVP and CCO | SSale | −2.87K | $0.82 | −$2.35K | −2.2%128.2K after | Amended10b5-1 |
| Jul 3, 2025 (view filing) | Jul 1 | 2 days | Strobeck MarkPresident and CEO | SSale | −6.93K | $0.82 | −$5.68K | −2.0%337.8K after | Amended10b5-1 |
| Jul 3, 2025 (view filing) | Jul 1 | 2 days | Neri JesseSVP and CFO | SSale | −886 | $0.82 | −$726.52 | −0.7%126.6K after | Amended10b5-1 |
| Apr 15, 2025 (view filing) | Apr 10-11 | 5 daysLate | Irrevocable Larson Family Investment Trust10% Owner | PPurchase | +87.5K | $1.07 | +$94.1K | +2.5%3.56M after | 30 lots |
| Apr 2, 2025 (view filing) | Apr 1 | 1 day | Strobeck MarkPresident and CEO | SSale | −6.93K | $1.08 | −$7.48K | −5.3%124.7K after | 10b5-1 |
| Apr 2, 2025 (view filing) | Apr 1 | 1 day | Neri JesseSVP, FINANCE AND CFO | SSale | −886 | $1.10 | −$974.6 | −2.9%30.0K after | 10b5-1 |
| Apr 2, 2025 (view filing) | Apr 1 | 1 day | Chole TimothySVP, Chief Commercial Officer | SSale | −2.87K | $1.08 | −$3.10K | −5.9%46.0K after | 10b5-1 |
| Jan 6, 2025 (view filing) | Jan 2 | 4 days | Chole TimothySVP, Chief Commercial Officer | SSale | −1.00K | $2.05 | −$2.05K | −1.8%54.2K after | 10b5-1 |
| Jan 6, 2025 (view filing) | Jan 2 | 4 days | Strobeck MarkPresident and CEO | SSale | −2.16K | $2.06 | −$4.46K | −1.5%145.0K after | 10b5-1 |
| Nov 19, 2024 (view filing) | Nov 15 | 4 days | Ravich Mark HDirector | SSale | −10.0K | $2.40 | −$24.0K | −7.6%121.4K after | |
| Nov 19, 2024 (view filing) | Nov 15 | 4 days | Ravich Mark HDirector | SSale | −20.0K | $2.32 | −$46.4K | −100.0%0 after | |
| Oct 2, 2024 (view filing) | Oct 1 | 1 day | Chole TimothySVP, Chief Commercial Officer | SSale | −1.00K | $3.69 | −$3.69K | −1.8%55.2K after | 10b5-1 |
| Oct 2, 2024 (view filing) | Oct 1 | 1 day | Strobeck MarkPresident and CEO | SSale | −2.16K | $3.69 | −$7.98K | −1.4%147.2K after | 10b5-1 |